SQURPHARMA share price
Square Pharmaceuticals PLC. · Pharmaceuticals & Chemicals · Category A
Price
Closing prices, 19 Nov 2026 Live prices free with an account
- Previous close
- ৳210.30
- Day range
- 209.60 – 210.50
- Volume
- 4,01,976
- Turnover
- ৳8.4Cr
SQURPHARMA price over the last year
Daily closing prices from DSE, not adjusted for bonus or rights issues.
Reported earnings and NAV
| Period | EPS | NAV / share | NOCFPS |
|---|---|---|---|
| FY27 Q1 | 8.77 | 187.35 | 5.49 |
| FY26 Annual | 31.24 | 178.99 | 18.65 |
| FY26 Q3 | 6.73 | 169.79 | 17.54 |
| FY26 Q2 | 8.20 | 162.41 | 13.16 |
| FY26 Q1 | 8.35 | 167.50 | 7.55 |
| FY25 Annual | 27.04 | 157.88 | 19.52 |
| FY25 Q3 | 6.83 | 151.94 | 11.90 |
| FY25 Q2 | 7.45 | 145.52 | 8.28 |
Per-share figures in taka, as published on DSE. Interim EPS is for the period, not annualised.
Latest DSE announcements
-
Trading of the shares of the company will resume on 17-Nov-2026.
-
Trading of the shares of the company will remain suspended on record date i.e., 16-Nov-2026.
-
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 12.11.2026 to 15.11.2026 and trading of the shares will remain suspended on record date i.e., 16.11.2026.
-
(Q1 Un-audited): Consolidated EPS was Tk. 8.77 for July-September 2026 as against Tk. 8.35 for July-September 2025. Consolidated NOCFPS was Tk. 5.49 for July-September 2026 as against Tk. 7.55 for July-September 2025. Consolidated NAV per share was Tk. 187.35 as on September 30, 2026 and Tk. 178.99 as on June 30, 2026. (cont.)
-
(Cont. News of SQURPHARMA): Reasons for deviation: NOCFPS decreased mainly because cash costs grew much faster than collections, Payments to suppliers and for manufacturing and operating expenses grew at a much faster pace than receipts from customers. Higher income tax payments further reduced net operating cash flow. (end)
-
Mrs. Ratna Patra, a Directors of the Company, has expressed her intention to buy 1,750,000 shares of the company at the prevailing market price in both the Public and Block Markets through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.
Other Pharmaceuticals & Chemicals shares
| Ticker | Price | % | Turnover |
|---|---|---|---|
| ASIATICLABAsiatic Laboratories Limited | 116.70 | +1.83% | ৳16.3Cr |
| WATACHEMWata Chemicals Limited | 183.10 | +8.22% | ৳11.0Cr |
| ACMELABThe ACME Laboratories Limited | 77.50 | -3.73% | ৳3.2Cr |
| ORIONINFUOrion Infusion Ltd. | 202.80 | -0.44% | ৳2.9Cr |
| ACMEPLACME Pesticides Limited | 24.50 | -0.41% | ৳2.8Cr |
| NAVANAPHARNavana Pharmaceuticals PLC | 64.80 | 0.00% | ৳2.0Cr |
SQURPHARMA: common questions
What is SQURPHARMA's share price?
SQURPHARMA closed at ৳209.70 on the Dhaka Stock Exchange (Closing prices, 19 Nov 2026), -0.60 (-0.29%) from the previous close of ৳210.30.
What is SQURPHARMA's 52-week high and low?
Between 23 Nov 2025 and 19 Nov 2026, SQURPHARMA traded as high as ৳236 and as low as ৳198 on DSE.
What is SQURPHARMA's P/E ratio?
At ৳209.70, SQURPHARMA's P/E ratio is 6.71, on its FY26 earnings per share of ৳31.24.
What dividend did SQURPHARMA declare?
For 2026, Square Pharmaceuticals PLC. declared a 130% cash dividend. Percentages are of the ৳10 face value.
Which sector is SQURPHARMA in?
Square Pharmaceuticals PLC. is listed in the Pharmaceuticals & Chemicals sector of the Dhaka Stock Exchange, in category A.
Prices, trades and company figures are from the Dhaka Stock Exchange; prices are at least 15 minutes old. Trakkr is not affiliated with DSE, and nothing here is investment advice.